Aerie pharmaceuticals to participate in upcoming virtual investor conferences

Durham, n.c.--(business wire)--aerie pharmaceuticals, inc. (nasdaq: aeri), an ophthalmic pharmaceutical company focused on the discovery, development and commercialization of first-in-class therapies for the treatment of patients with open-angle glaucoma, ocular surface diseases and retinal diseases, today announced that the company will participate in the following virtual investor conferences. 10th annual svb leerink global healthcare conference date: friday, february 26, 2021 time: 2:20 p.m.
AERI Ratings Summary
AERI Quant Ranking